Gapping upNews:
- KSS +26.6% (Starboard Value consortium aiming to bid $64/share for Kohl's)
- CTSO +11.5% (New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology)
- SABS +6.8% (Reports Positive Phase 2 Virology Data Demonstrating SAB-185 Met Criteria for Advancement to Phase 3 in NIH ACTIV-2 Trial for Treatment of COVID-19)
- UL +6.7% (Trian Partners purchased stake in Unilever)
- VOD +6.6% (discussions to combine Italian units with Iliad; mulling acquisition of Three UK)
- ATGE +6% (divests Financial Services Segment) .
Analyst comments:
- FOXA +2.2% (upgraded to Buy from Neutral at UBS)
- CMCSA +1.7% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- ANET +1.6% (upgraded to Buy from Neutral at Citigroup)
- CHTR +1% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- RMD +0.8% (upgraded to Neutral from Underperform at BofA Securities)